Aysim Yilmaz

677 total citations
7 papers, 556 citations indexed

About

Aysim Yilmaz is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Aysim Yilmaz has authored 7 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Oncology. Recurrent topics in Aysim Yilmaz's work include Angiogenesis and VEGF in Cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Aysim Yilmaz is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Aysim Yilmaz collaborates with scholars based in Switzerland, France and Germany. Aysim Yilmaz's co-authors include Curzio Rüegg, Grégory Bieler, Ferdy J. Lejeune, Pascal Chaubert, J. Bamat, Harald Lahm, Jean‐Claude Givel, Jürgen R. Fischer, Josiane Wyniger and Paul Amstad and has published in prestigious journals such as Nature Medicine, Biochemical and Biophysical Research Communications and International Journal of Cancer.

In The Last Decade

Aysim Yilmaz

7 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aysim Yilmaz Switzerland 5 301 174 170 131 125 7 556
Fred Elfman United States 14 328 1.1× 141 0.8× 141 0.8× 125 1.0× 114 0.9× 21 600
Paul Perrotte Canada 7 284 0.9× 216 1.2× 112 0.7× 179 1.4× 42 0.3× 12 552
Cornelia Hansmann Austria 7 260 0.9× 97 0.6× 164 1.0× 246 1.9× 209 1.7× 7 661
Kazuko Yamaoka Japan 9 263 0.9× 114 0.7× 125 0.7× 43 0.3× 44 0.4× 12 541
Giovanni Roveroni Italy 11 173 0.6× 197 1.1× 87 0.5× 195 1.5× 50 0.4× 18 523
Yingfu Liu China 14 297 1.0× 167 1.0× 116 0.7× 131 1.0× 43 0.3× 19 559
Oksana I. Dukhanina United States 7 517 1.7× 393 2.3× 110 0.6× 91 0.7× 52 0.4× 13 779
Shinsuke Saito Japan 9 205 0.7× 173 1.0× 88 0.5× 135 1.0× 45 0.4× 19 411
Gregory Kumkumian United States 8 120 0.4× 157 0.9× 87 0.5× 144 1.1× 109 0.9× 8 507
M. Collette France 11 251 0.8× 398 2.3× 71 0.4× 121 0.9× 62 0.5× 15 644

Countries citing papers authored by Aysim Yilmaz

Since Specialization
Citations

This map shows the geographic impact of Aysim Yilmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aysim Yilmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aysim Yilmaz more than expected).

Fields of papers citing papers by Aysim Yilmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aysim Yilmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aysim Yilmaz. The network helps show where Aysim Yilmaz may publish in the future.

Co-authorship network of co-authors of Aysim Yilmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Aysim Yilmaz. A scholar is included among the top collaborators of Aysim Yilmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aysim Yilmaz. Aysim Yilmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Yilmaz, Aysim, Grégory Bieler, Olivier Spertini, Ferdy J. Lejeune, & Curzio Rüegg. (1998). Pulse treatment of human vascular endothelial cells with high doses of tumor necrosis factor and interferon‐gamma results in simultaneous synergistic and reversible effects on proliferation and morphology. International Journal of Cancer. 77(4). 592–599. 2 indexed citations
2.
Yilmaz, Aysim, Grégory Bieler, Olivier Spertini, Ferdy J. Lejeune, & Curzio Rüegg. (1998). Pulse treatment of human vascular endothelial cells with high doses of tumor necrosis factor and interferon-gamma results in simultaneous synergistic and reversible effects on proliferation and morphology. International Journal of Cancer. 77(4). 592–599. 30 indexed citations
3.
Rüegg, Curzio, Aysim Yilmaz, Grégory Bieler, et al.. (1998). Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γ. Nature Medicine. 4(4). 408–414. 368 indexed citations
5.
Lahm, Harald, Paul Amstad, Aysim Yilmaz, et al.. (1996). Differential Effect of Interleukin-4 and Transforming Growth Factor β1 on Expression of Proto-oncogenes and Autocrine Insulin-like Growth Factor II in Colorectal Carcinoma Cells. Biochemical and Biophysical Research Communications. 220(2). 334–340. 8 indexed citations
6.
Lahm, Harald, Paul Amstad, Josiane Wyniger, et al.. (1994). Blockade of the insulin‐like growth‐factor‐I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF‐II‐mediated autocrine loop. International Journal of Cancer. 58(3). 452–459. 115 indexed citations
7.
Lahm, Harald, Bruno Schnyder, Josiane Wyniger, et al.. (1994). Growth inhibition of human colorectal‐carcinoma cells by interleukin‐4 and expression of functional interleukin‐4 receptors. International Journal of Cancer. 59(3). 440–447. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026